uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
uniQure N.V. - Ordinary Shares (QURE)
Today's Latest Price: $36.30 USD
Updated Jan 27 4:00pm
Add QURE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
QURE Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for QURE is 0.03 -- better than only 10.32% of US stocks.
- Of note is the ratio of uniQure NV's sales and general administrative expense to its total operating expenses; only 13.03% of US stocks have a lower such ratio.
- With a price/sales ratio of 281.18, uniQure NV has a higher such ratio than 98.05% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to uniQure NV, a group of peers worth examining would be AUTL, FIXX, CKPT, RAPT, and BBIO.
- Visit QURE's SEC page to see the company's official filings. To visit the company's web site, go to www.uniqure.com.
QURE Stock Price Chart Interactive Chart >
QURE Price/Volume Stats
| Current price | $36.30 | 52-week high | $71.45 |
| Prev. close | $38.25 | 52-week low | $34.38 |
| Day low | $36.05 | Volume | 486,466 |
| Day high | $38.46 | Avg. volume | 394,588 |
| 50-day MA | $42.71 | Dividend yield | N/A |
| 200-day MA | $46.52 | Market Cap | 1.62B |
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
Loading social stream, please wait...